PMID: 29490210Mar 1, 2018Paper

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary

The Medical Journal of Australia
Gin S MalhiKristina Fritz

Abstract

In December 2015, the Royal Australian and New Zealand College of Psychiatrists published a comprehensive set of mood disorder clinical practice guidelines for psychiatrists, psychologists and mental health professionals. This guideline summary, directed broadly at primary care physicians, is an abridged version that focuses on major depression. It emphasises the importance of shared decision making, tailoring personalised care to the individual, and delivering care in the context of a therapeutic relationship. In practice, the management of depression is determined by a multitude of factors, including illness severity and putative aetiology, with the principal objectives of regaining premorbid functioning and improving resilience against recurrence of future episodes. Main recommendations: The guidelines emphasise a biopsychosocial lifestyle approach and provide the following specific clinical recommendations: Alongside or before prescribing any form of treatment, consideration should be given to the implementation of strategies to manage stress, ensure appropriate sleep hygiene and enable uptake of healthy lifestyle changes. For mild to moderate depression, psychological management alone is an appropriate first line treatment...Continue Reading

References

Oct 6, 2000·Acta Psychiatrica Scandinavica. Supplementum·S PerettiI Hindmarch
Jul 5, 2001·The Australian and New Zealand Journal of Psychiatry·K RoyK Wilhelm
Apr 29, 2003·The Journal of Clinical Psychiatry·Roger T MulderSuzanne E Luty
Jan 1, 1959·The British Journal of Medical Psychology·M HAMILTON
Jun 24, 2004·The Australian and New Zealand Journal of Psychiatry·Peter Ellis, UNKNOWN Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Depression
Jul 9, 2004·Archives of General Psychiatry·Sandro PampallonaCarmine Munizza
Mar 24, 2006·The New England Journal of Medicine·A John RushUNKNOWN STAR*D Study Team
Dec 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Judit SimonDavid Goldberg
Jul 11, 2007·The Australian and New Zealand Journal of Psychiatry·Edmund SilinsPaul Dillon
Dec 11, 2007·Journal of Affective Disorders·Elisabeth SchrammMathias Berger
Jun 11, 2008·Journal of Consulting and Clinical Psychology·Rachel ManberMartin E Keller
Aug 23, 2008·European Archives of Psychiatry and Clinical Neuroscience·Hans-Jürgen MöllerUNKNOWN WPA Section on Pharmacopsychiatry
Apr 9, 2009·The Medical Journal of Australia·Michael K NicholasGin Singh Malhi
Apr 16, 2009·Acta Psychiatrica Scandinavica. Supplementum·G S MalhiUNKNOWN CADE Clinic, University of Sydney
Jan 22, 2010·Journal of Affective Disorders·Hiroko SugawaraJun Ishigooka
Dec 21, 2010·Annual Review of Clinical Psychology·Allison G Harvey
Sep 5, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Christopher BridleSarah E Lamb
Mar 28, 2013·Human Psychopharmacology·Dan J SteinSidney H Kennedy
Apr 23, 2013·Acta Psychiatrica Scandinavica. Supplementum·G S MalhiK Fritz
Aug 9, 2013·Acta Psychiatrica Scandinavica. Supplementum·G S Malhi, S Kuiper
Nov 22, 2013·Journal of Personality Disorders·Giles Newton-HowesRobert Schoevers
Nov 28, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Brendan D HareWilliam A Falls
Jun 13, 2014·The Journal of Clinical Psychiatry·Bradley N GaynesKathleen N Lohr
Jun 17, 2014·Development and Psychopathology·Albertine J OldehinkelEsther Nederhof
Sep 8, 2010·The Cochrane Database of Systematic Reviews·Vivien HunotRachel Churchill
Dec 9, 2015·The Australian and New Zealand Journal of Psychiatry·Gin S MalhiAjeet B Singh
Mar 28, 2017·The Australian and New Zealand Journal of Psychiatry·Gin S MalhiTim Outhred
May 4, 2017·Journal of Psychopharmacology·Becky MarsDavid Kessler
Jun 10, 2017·Bipolar Disorders·Gordon ParkerGin S Malhi
Jul 30, 2017·The Australian and New Zealand Journal of Psychiatry·Bill LyndonGin S Malhi

❮ Previous
Next ❯

Citations

Mar 5, 2020·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Evelyn KleemannFelipe B Schuch
Nov 1, 2018·The Australian and New Zealand Journal of Psychiatry·Augustus John RushKoen Demyttenaere
Feb 23, 2019·BMC Psychiatry·Jessica Hanae Zafra-TanakaAlvaro Taype-Rondan
Jan 14, 2019·The Medical Journal of Australia·Philip M Boyce, Fiona Judd
Feb 7, 2019·The Australian and New Zealand Journal of Psychiatry·Darryl BassettGin S Malhi
Jul 1, 2020·Frontiers in Psychiatry·Claire O'Donovan, Martin Alda
Feb 26, 2019·Journal of Affective Disorders·Laura M HackBoadie W Dunlop
Mar 16, 2021·Journal of Palliative Medicine·Minurika PerusingheBrett McDermott
Jun 1, 2021·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Eduard VietaAndrea Gabilondo
Aug 27, 2021·Case Reports in Psychiatry·Tomosuke NakanoMotohiro Okada

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.